PYOTT DAVID E I
Insider CIK 1051578 · BMRN Director · EW Director · ALNY Director · PLRX Director · TARS Director · AGN Chairman, President and CEO, Director · AVY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-09-15 | 2026-09-17 | 201 | — | $0 | 605 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-09-15 | 2026-09-17 | 201 | — | $0 | 9,575 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-09-15 | 2026-09-17 | 201 | — | $0 | 605 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-09-15 | 2026-09-17 | 201 | — | — | 9,575 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-06-25 | 2026-06-29 | 3,837 | — | $0 | 3,837 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-06-25 | 2026-06-29 | 2,417 | — | $0 | 2,417 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-06-25 | 2026-06-29 | 806 | — | $0 | 806 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2026-06-01 | 2026-06-03 | 3,830 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-06-01 | 2026-06-03 | 1,222 | $299.87 | $366.4K | 2,094 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2026-06-01 | 2026-06-03 | 3,830 | — | $0 | 5,412 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-06-01 | 2026-06-03 | 495 | $300.72 | $148.9K | 1,599 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-06-01 | 2026-06-03 | 921 | $297.71 | $274.2K | 4,491 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-06-01 | 2026-06-03 | 17 | $302.65 | $5.1K | 1,582 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-06-01 | 2026-06-03 | 1,175 | $298.91 | $351.2K | 3,316 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-05-20 | 2026-05-22 | 1,441 | — | $0 | 1,441 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-05-20 | 2026-05-22 | 671 | — | $0 | 1,582 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-04-24 | 2026-04-28 | 1,383 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-04-24 | 2026-04-28 | 1,383 | — | $0 | 1,383 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-02-18 | 2026-02-20 | 3,729 | — | $0 | 3,729 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-02-18 | 2026-02-20 | 5,893 | — | $0 | 5,893 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-05-08 | 2025-05-12 | 1,558 | — | $0 | 1,558 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-05-08 | 2025-05-12 | 775 | — | $0 | 911 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-03-24 | 2025-03-25 | 7,440 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-24 | 2025-03-25 | 7,440 | $299.00 | $2.22M | 136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-03-24 | 2025-03-25 | 7,440 | $88.95 | $661.8K | 7,576 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-06-24 | 2024-06-26 | 7,420 | — | $0 | 3,830 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-06-24 | 2024-06-26 | 7,470 | — | $0 | 3,780 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-06-24 | 2024-06-26 | 17,560 | — | $0 | 7,440 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-06-24 | 2024-06-26 | 7,470 | $71.99 | $537.8K | 32,586 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-06-24 | 2024-06-26 | 17,560 | $88.95 | $1.56M | 17,696 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-24 | 2024-06-26 | 7,420 | $221.00 | $1.64M | 7,606 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-24 | 2024-06-26 | 17,560 | $220.00 | $3.86M | 15,026 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-24 | 2024-06-26 | 7,470 | $222.00 | $1.66M | 136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-06-24 | 2024-06-26 | 7,420 | $70.20 | $520.9K | 25,116 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-05-21 | 2024-05-23 | 4,720 | — | $0 | 49,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-05-16 | 2024-05-20 | 5,228 | — | $0 | 5,228 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-05-23 | 2023-05-24 | 4,190 | — | $0 | 45,030 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-05-18 | 2023-05-19 | 3,454 | — | $0 | 3,454 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-02-23 | 2023-02-27 | 136 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-02-23 | 2023-02-27 | 136 | — | $0 | 136 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-05-24 | 2022-05-26 | 4,980 | — | $0 | 40,840 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-05-18 | 2022-05-20 | 5,153 | — | $0 | 5,153 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 136 | — | $0 | 136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-07-15 | 2021-07-19 | 4,032 | — | $0 | 4,032 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-06-29 | 2021-07-01 | 13,286 | — | $0 | 13,286 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-05-25 | 2021-05-27 | 5,120 | — | $0 | 35,860 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-01-12 | 2021-01-13 | 26,573 | — | $0 | 26,573 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | P Buy | 2020-08-31 | 2020-09-01 | 11,900 | $78.22 | $930.8K | 29,840 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | P Buy | 2020-08-31 | 2020-09-01 | 900 | $78.84 | $71.0K | 30,740 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-07-01 | 2020-07-06 | 4,581 | — | $0 | 4,581 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-05-27 | 2020-05-29 | 4,300 | — | $0 | 17,940 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2020-04-23 | 2020-04-24 | 1,414 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2020-04-23 | 2020-04-24 | 1,414 | $107.56 | $152.1K | 18,684 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2020-02-03 | 2020-02-05 | 5,027 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | S Sale | 2020-02-03 | 2020-02-05 | 5,027 | $132.72 | $667.2K | 17,270 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2020-02-03 | 2020-02-05 | 5,027 | $38.18 | $191.9K | 22,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-07-01 | 2019-07-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-06-04 | 2019-06-06 | 4,430 | — | $0 | 13,640 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2019-05-01 | 2019-05-02 | 1,336 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2019-05-01 | 2019-05-02 | 1,414 | — | $0 | 1,414 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2019-05-01 | 2019-05-02 | 641 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2019-05-01 | 2019-05-02 | 641 | $109.63 | $70.3K | 15,934 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2019-05-01 | 2019-05-02 | 1,336 | $109.63 | $146.5K | 17,270 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2018-11-27 | 2018-11-28 | 2,000 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | S Sale | 2018-11-27 | 2018-11-28 | 2,000 | $93.00 | $186.0K | 15,293 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2018-11-27 | 2018-11-28 | 2,000 | $20.64 | $41.3K | 17,293 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-06-20 | 2018-06-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-06-05 | 2018-06-07 | 4,300 | — | $0 | 9,210 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2018-05-01 | 2018-05-02 | 641 | — | $0 | 641 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2018-05-01 | 2018-05-02 | 747 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2018-05-01 | 2018-05-02 | 1,678 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2018-05-01 | 2018-05-02 | 1,336 | — | $0 | 1,336 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2018-05-01 | 2018-05-02 | 641 | $104.80 | $67.2K | 13,615 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2018-05-01 | 2018-05-02 | 1,678 | $104.80 | $175.9K | 15,293 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2018-05-01 | 2018-05-02 | 747 | $104.80 | $78.3K | 12,974 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2017-08-30 | 2017-08-30 | 1,702 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | S Sale | 2017-08-30 | 2017-08-30 | 1,702 | $94.00 | $160.0K | 16,303 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2017-08-30 | 2017-08-30 | 1,702 | $52.12 | $88.7K | 18,005 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2017-08-28 | 2017-08-30 | 298 | — | $0 | 1,702 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2017-08-28 | 2017-08-30 | 298 | $52.12 | $15.5K | 16,601 | SEC↗ |
| AVY Avery Dennison Corp | S Sale | 2017-08-28 | 2017-08-30 | 298 | $94.00 | $28.0K | 16,303 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-06-06 | 2017-06-08 | 4,910 | — | $0 | 4,910 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-06-06 | 2017-06-08 | 2,050 | — | $0 | 4,910 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-06-02 | 2017-06-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2017-05-01 | 2017-05-03 | 746 | — | $0 | 747 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2017-05-01 | 2017-05-03 | 859 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2017-05-01 | 2017-05-03 | 640 | — | $0 | 1,282 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2017-05-01 | 2017-05-03 | 1,678 | — | $0 | 1,678 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2017-05-01 | 2017-05-03 | 859 | $83.42 | $71.7K | 14,917 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2017-05-01 | 2017-05-03 | 640 | $83.42 | $53.4K | 16,303 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2017-05-01 | 2017-05-03 | 746 | $83.42 | $62.2K | 15,663 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2016-10-13 | 2016-10-14 | 27,900 | $37.00 | $1.03M | 27,900 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2016-08-08 | 2016-08-09 | 2,000 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2016-08-08 | 2016-08-09 | 2,000 | $67.80 | $135.6K | 16,058 | SEC↗ |
| AVY Avery Dennison Corp | S Sale | 2016-08-08 | 2016-08-09 | 2,000 | $78.61 | $157.2K | 14,058 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-06-06 | 2016-06-08 | 2,220 | — | $0 | 2,220 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-06-06 | 2016-06-08 | 760 | — | $0 | 2,860 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-06-03 | 2016-06-07 | 11,250 | — | $0 | 11,250 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2016-05-01 | 2016-05-02 | 1,922 | — | $0 | 1,922 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2016-04-29 | 2016-05-02 | 1,015 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2016-04-29 | 2016-05-02 | 859 | — | $0 | 859 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2016-04-29 | 2016-05-02 | 746 | — | $0 | 1,493 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2016-04-29 | 2016-05-02 | 859 | $72.82 | $62.6K | 13,312 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2016-04-29 | 2016-05-02 | 1,015 | $72.82 | $73.9K | 12,453 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2016-04-29 | 2016-05-02 | 746 | $72.82 | $54.3K | 14,058 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-01-04 | 2016-01-06 | 6,100 | — | $0 | 6,100 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-01-04 | 2016-01-06 | 2,100 | — | $0 | 2,100 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-12-18 | 2015-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2015-11-02 | 2015-11-03 | 2,000 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2015-11-02 | 2015-11-03 | 2,000 | $59.47 | $118.9K | 13,438 | SEC↗ |
| AVY Avery Dennison Corp | S Sale | 2015-11-02 | 2015-11-03 | 2,000 | $64.88 | $129.8K | 11,438 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2015-05-01 | 2015-05-04 | 1,015 | — | $0 | 1,015 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2015-05-01 | 2015-05-04 | 2,239 | — | $0 | 2,239 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2015-05-01 | 2015-05-04 | 859 | — | $0 | 1,718 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2015-05-01 | 2015-05-04 | 1,015 | $55.84 | $56.7K | 10,579 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2015-05-01 | 2015-05-04 | 859 | $55.84 | $48.0K | 11,438 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2015-04-26 | 2015-04-28 | 524 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2015-04-26 | 2015-04-28 | 524 | $51.77 | $27.1K | 9,564 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 303,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 386,800 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 257,756 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 422,400 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 410,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 533,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 312,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer deriv | 2015-03-17 | 2015-03-19 | 375,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 165,658 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 2,897 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 2,180 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | D To issuer | 2015-03-17 | 2015-03-19 | 114,548 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2015-02-20 | 2015-02-24 | 1,379 | — | $0 | 1,379 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2015-02-20 | 2015-02-24 | 1,379 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2015-02-20 | 2015-02-24 | 720 | $234.00 | $168.5K | 165,659 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2015-02-20 | 2015-02-24 | 1,379 | — | $0 | 166,379 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2015-02-12 | 2015-03-19 | 114,548 | — | $0 | 114,548 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2014-12-01 | 2014-12-02 | 1,119 | — | $0 | 39,412 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award deriv | 2014-05-09 | 2014-05-13 | 1,874 | — | $0 | 1,874 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2014-05-09 | 2014-05-13 | 2,342 | — | $0 | 53,582 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2014-05-01 | 2014-05-02 | 1,015 | — | $0 | 2,030 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2014-05-01 | 2014-05-02 | 2,577 | — | $0 | 2,577 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2014-05-01 | 2014-05-02 | 1,289 | — | $0 | 37,754 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2014-05-01 | 2014-05-02 | 1,015 | $48.50 | $49.2K | 9,040 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2014-04-28 | 2014-04-29 | 391 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2014-04-28 | 2014-04-29 | 391 | $48.82 | $19.1K | 8,025 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2014-04-26 | 2014-04-29 | 523 | — | $0 | 524 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2014-04-26 | 2014-04-29 | 523 | $48.71 | $25.5K | 7,634 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2014-02-21 | 2014-02-25 | 257,756 | $125.07 | $32.24M | 257,756 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2014-02-12 | 2014-02-13 | 252,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2014-02-12 | 2014-02-13 | 252,000 | $36.15 | $9.11M | 417,000 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2014-02-12 | 2014-02-13 | 252,000 | $123.12 | $31.03M | 165,000 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2013-12-01 | 2013-12-03 | 1,278 | — | $0 | 36,046 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award deriv | 2013-05-15 | 2013-05-17 | 2,250 | — | $0 | 2,250 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2013-05-15 | 2013-05-17 | 2,811 | — | $0 | 51,240 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2013-05-01 | 2013-05-02 | 774 | — | $0 | 34,313 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2013-05-01 | 2013-05-02 | 3,045 | — | $0 | 3,045 | SEC↗ |
| EW Edwards Lifesciences Corp | P Buy | 2013-05-01 | 2013-05-01 | 3,000 | $62.95 | $188.8K | 48,429 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2013-04-26 | 2013-04-29 | 390 | — | $0 | 391 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2013-04-26 | 2013-04-29 | 522 | — | $0 | 1,047 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2013-04-26 | 2013-04-29 | 390 | $41.52 | $16.2K | 6,589 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2013-04-26 | 2013-04-29 | 522 | $41.52 | $21.7K | 7,111 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2013-04-22 | 2013-04-23 | 436 | — | $0 | 0 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2013-04-22 | 2013-04-23 | 436 | $40.85 | $17.8K | 6,199 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2013-04-01 | 2013-04-02 | 983 | — | $0 | 33,539 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2013-02-21 | 2013-02-22 | 303,000 | — | $0 | 303,000 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2012-12-19 | 2012-12-20 | 1,233 | — | $0 | 32,556 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-10-05 | 2012-10-05 | 307,956 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-10-05 | 2012-10-05 | 307,956 | $93.72 | $28.86M | 229,096 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-10-05 | 2012-10-05 | 307,956 | $41.24 | $12.70M | 537,052 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-10-04 | 2012-10-05 | 90,623 | — | $0 | 409,377 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-10-04 | 2012-10-05 | 101,421 | — | $0 | 307,956 | SEC↗ |
| AGN ALLERGAN INC | M Exercise deriv | 2012-10-04 | 2012-10-05 | 119,000 | — | $0 | 0 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-10-04 | 2012-10-05 | 90,623 | $41.24 | $3.74M | 229,096 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-10-04 | 2012-10-05 | 206,923 | $93.74 | $19.40M | 19,473 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-10-04 | 2012-10-05 | 119,000 | $30.13 | $3.59M | 138,473 | SEC↗ |
| AGN ALLERGAN INC | M Exercise | 2012-10-04 | 2012-10-05 | 101,421 | $41.24 | $4.18M | 330,517 | SEC↗ |
| AGN ALLERGAN INC | S Sale | 2012-10-04 | 2012-10-05 | 101,421 | $93.71 | $9.50M | 229,096 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2012-09-28 | 2012-10-02 | 1,179 | — | $0 | 31,323 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2012-09-21 | 2012-10-05 | 19,473 | — | $0 | 226,396 | SEC↗ |
| AGN ALLERGAN INC | G Gift | 2012-09-21 | 2012-10-05 | 19,473 | — | $0 | 165,000 | SEC↗ |
| EW Edwards Lifesciences Corp | M Exercise deriv | 2012-08-06 | 2012-08-08 | 3,278 | — | $0 | 0 | SEC↗ |
| EW Edwards Lifesciences Corp | M Exercise deriv | 2012-08-06 | 2012-08-08 | 3,520 | — | $0 | 0 | SEC↗ |
| EW Edwards Lifesciences Corp | M Exercise | 2012-08-06 | 2012-08-08 | 3,520 | $22.72 | $80.0K | 48,949 | SEC↗ |
| EW Edwards Lifesciences Corp | M Exercise | 2012-08-06 | 2012-08-08 | 3,278 | $24.42 | $80.0K | 52,227 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2012-08-06 | 2012-08-08 | 6,798 | $100.65 | $684.2K | 45,429 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2012-06-29 | 2012-07-02 | 1,304 | — | $0 | 30,144 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2012-05-16 | 2012-05-18 | 312,000 | — | $0 | 312,000 | SEC↗ |
| AGN ALLERGAN INC | G Gift deriv | 2012-05-16 | 2012-05-18 | 312,000 | — | $0 | 0 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award deriv | 2012-05-11 | 2012-05-14 | 1,890 | — | $0 | 1,890 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2012-05-11 | 2012-05-14 | 2,361 | — | $0 | 45,429 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2012-04-27 | 2012-04-30 | 389 | — | $0 | 781 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2012-04-27 | 2012-04-30 | 389 | $32.36 | $12.6K | 5,763 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2012-04-26 | 2012-04-30 | 6,318 | — | $0 | 6,318 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2012-04-26 | 2012-04-30 | 1,569 | — | $0 | 1,569 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise deriv | 2012-04-20 | 2012-04-23 | 437 | — | $0 | 436 | SEC↗ |
| AVY Avery Dennison Corp | M Exercise | 2012-04-20 | 2012-04-23 | 437 | $31.33 | $13.7K | 5,374 | SEC↗ |
| AVY Avery Dennison Corp | A Award deriv | 2012-03-30 | 2012-04-02 | 1,338 | — | $0 | 28,840 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-02-17 | 2012-02-22 | 312,000 | — | $0 | 312,000 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2012-02-17 | 2012-02-22 | 955 | $87.91 | $84.0K | 183,518 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2012-02-17 | 2012-02-22 | 2,045 | — | $0 | 185,563 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2012-02-17 | 2012-02-22 | 165,000 | — | $0 | 184,473 | SEC↗ |
| AGN ALLERGAN INC | F Tax w/h | 2012-02-14 | 2012-02-16 | 12,869 | $88.11 | $1.13M | 18,383 | SEC↗ |
| EW Edwards Lifesciences Corp | M Exercise deriv | 2012-01-18 | 2012-01-18 | 20,000 | — | $0 | 0 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2012-01-18 | 2012-01-18 | 20,000 | $76.95 | $1.54M | 43,068 | SEC↗ |
| EW Edwards Lifesciences Corp | M Exercise | 2012-01-18 | 2012-01-18 | 20,000 | $12.89 | $257.8K | 63,068 | SEC↗ |